Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), Center for Research on Epidemiology and Statistics Sorbonne Paris Cité (CRESS), INSERM, INRA, Université de Paris Cité, Paris, France.
Maternité Port Royal, Hôpital Cochin Port Royal, Assistance Publique-Hôpitaux de Paris, Université de Paris Cité, Paris, France.
Acta Obstet Gynecol Scand. 2023 Mar;102(3):301-312. doi: 10.1111/aogs.14496. Epub 2023 Jan 26.
Research on maternal prepregnancy weight suggests adiposity is associated with dysfunctional labor, but knowledge about how gestational weight gain (GWG) affects labor is sparse. Our objective was to evaluate associations between GWG adequacy and intrapartum obstetric interventions (oxytocin administration; cesarean section) necessitated by labor dysfunction.
Using national, population-based French National Perinatal Survey 2016 data, we included term cephalic singleton pregnancies involving trial of labor (n = 9724). For the intrapartum oxytocin administration analysis, we included only women with spontaneous labor (n = 7352). GWG was calculated as the difference between end of pregnancy and prepregnancy weight (both self-reported) and categorized as insufficient, adequate (reference group), or excessive by prepregnancy body mass index (BMI; underweight <18.5, normal weight 18.5-24.9, overweight 25-29.9, obese ≥30 kg/m ) using the 2009 Institute of Medicine thresholds. Multilevel generalized estimating equation logistic regression models, unadjusted and adjusted for a priori confounders, evaluated intervention-GWG adequacy associations within BMI categories (under/normal weight combined), stratified by parity (primiparas; multiparas).
GWG adequacy was associated with oxytocin use among under/normal weight women (primiparas: insufficient 57.3%, adequate 60.8%, excessive 65.0%, p = 0.014; multiparas: insufficient 27.2%, adequate 29.1%, excessive 36.2%, p < 0.001) and overweight primiparas (insufficient 56.0%, adequate 58.7%, excessive 72.5%, p = 0.002). In unadjusted and adjusted models, trends of increased odds of oxytocin administration among women with excessive GWG were found regardless of parity and prepregnancy BMI. Similarly, among under/normal weight women, GWG adequacy was associated with intrapartum cesarean section (primiparas: insufficient 10.7%, adequate 12.7%, excessive 15.3%, p = 0.014; multiparas: insufficient 3.1%, adequate 3.5%, excessive 6.3%, p < 0.001) with increased cesarean section among multiparas with excessive GWG persisting in adjusted models (adjusted odds ratio 1.9, 95% confidence interval 1.3-2.7). However, intrapartum cesarean section was reduced among multiparas with overweight and obese prepregnancy BMI and excessive GWG.
Excessive GWG was associated with intrapartum oxytocin administration, regardless of parity or prepregnancy BMI, and cesarean section among women with under/normal weight prepregnancy BMI, providing evidence for benefits of healthy GWG for normal labor progression. Additional research is needed to verify our findings and understand differences by BMI.
关于孕产妇孕前体重的研究表明肥胖与功能失调性分娩有关,但关于妊娠体重增加(GWG)如何影响分娩的知识还很匮乏。我们的目的是评估 GWG 充足性与因分娩功能障碍而必需的产时产科干预(缩宫素使用;剖宫产)之间的关系。
利用全国性的法国 2016 年国家围产期调查的人群基础数据,我们纳入了足月头位单胎试产(n=9724)。对于产时缩宫素使用分析,我们仅纳入自然分娩的女性(n=7352)。GWG 是通过自我报告的妊娠末期和孕前体重之间的差异计算得出的,并根据孕前 BMI(<18.5 为体重不足,18.5-24.9 为正常体重,25-29.9 为超重,≥30kg/m 为肥胖)分为不足、充足(参考组)或过多。采用 2009 年医学研究所阈值,使用多水平广义估计方程逻辑回归模型,在 BMI 类别内(将低/正常体重合并),在初产妇和经产妇之间进行调整了先验混杂因素后,评估干预-GWG 充足性的关系。
GWG 充足性与低/正常体重妇女使用缩宫素有关(初产妇:不足 57.3%,充足 60.8%,过多 65.0%,p=0.014;经产妇:不足 27.2%,充足 29.1%,过多 36.2%,p<0.001)和超重初产妇(不足 56.0%,充足 58.7%,过多 72.5%,p=0.002)。在未调整和调整模型中,无论初产妇和孕前 BMI 如何,GWG 过多的女性使用缩宫素的几率都呈增加趋势。同样,在低/正常体重妇女中,GWG 充足性与产时剖宫产有关(初产妇:不足 10.7%,充足 12.7%,过多 15.3%,p=0.014;经产妇:不足 3.1%,充足 3.5%,过多 6.3%,p<0.001),并且在调整模型中,经产妇 GWG 过多与剖宫产的关系仍然存在(调整后的比值比 1.9,95%置信区间 1.3-2.7)。然而,超重和肥胖初产妇 GWG 过多与经产妇的剖宫产率降低有关。
GWG 过多与产时缩宫素的使用有关,无论初产妇或孕前 BMI 如何,并且与低/正常体重妇女的剖宫产有关,这为健康的 GWG 有利于正常分娩过程提供了证据。需要进一步的研究来验证我们的发现,并了解 BMI 差异。